Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Bicalutamide and Abemaciclib for Patients with Advanced Androgen Receptor Positive Triple-Negative Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on Immunotherapy with Atezolizumab, Tiragolumab, and Ipilimumab for Patients with Advanced Triple Negative Breast Cancer

    Recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study on Imatinib for Patients with Triple Negative Breast Cancer to Convert it to ER-Positive Breast Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Ireland Italy Spain
  • Neoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer

    Not yet recruiting

    1 1 1 1
    Germany
  • Testing sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer

    Not yet recruiting

    1 1 1
    Investigated diseases:
    France
  • Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

    Not yet recruiting

    1 1
    Investigated diseases:
    France
  • Study on Early Detection of Triple-Negative Breast Cancer Relapse Using [68Ga]Ga-FAPI-46 for Patients at High Risk

    Not yet recruiting

    1 1
    Investigated diseases:
    France
  • Study of ipatasertib with atezolizumab and chemotherapy in women with triple-negative breast cancer before surgery

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain